Press release
Inflammatory Bowel Disease Treatment Market to Witness Substantial Growth USD 30.80 Billion, with a Dynamic 4.7% Growth Rate by 2030
Inflammatory Bowel Disease Treatment Market
The market is experiencing significant growth and is expected to continue expanding in the coming years.
Albeit there is no corrective cure for inflammatory bowel disease treatment, it is feasible to reduce redness and confront indicators with several therapies. The aim of curing IBD involves halting ensuing eruption and palliative redness in the intestines, both in the lining and at a profound cellular level.
As IBD frequently creates problems in varied body parts, a cross-functional perspective to care can be of assistance. Experts in gastroenterology, colorectal surgery, rheumatology, dermatology, ophthalmology, and alternate areas work cohesively to enhance the standard of living for people with IBD. The cures might involve medicines, surgeries, and a gamut of provisions and lifestyle alterations that assist in decreasing redness and reinforcing the immune system.
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ ๐๐๐ข๐ง ๐๐จ๐ฆ๐ฉ๐ซ๐๐ก๐๐ง๐ฌ๐ข๐ฏ๐ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ: https://www.polarismarketresearch.com/industry-analysis/global-inflammatory-bowel-disease-ibd-market/request-for-sample
๐๐จ๐ฆ๐ฉ๐๐ญ๐ข๐ญ๐ข๐จ๐ง ๐๐๐ญ๐๐ ๐จ๐ซ๐ข๐ณ๐๐ญ๐ข๐จ๐ง
The spearheading players are now concentrating on putting programs into practice, such as utilizing contemporary technology, commodity inventions, acquisition and mergers, joint ventures, and alliances to enhance the market standing. Key companies in the inflammatory bowel disease treatment market are mentioned below:
โข AbbVie Inc.
โข Biogen
โข Johnson & Johnson Services
โข Inc.
โข Amgen Inc.
โข UCB S.A.
โข Novartis AG
โข Takeda Pharmaceutical Company Limited
โข Bausch health companies Inc.
โข Bristol-myers squibb company
โข Merck & co. Inc.
โข Pfizer Inc.
โข Celltrion Inc.
โข Janssen Biotech
โข Allergan plc.
๐๐๐ซ๐ค๐๐ญ ๐๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ
โข The demand for inflammatory bowel disease treatment is rising quickly due to growing cases of Crohn's disease and ulcerative colitis, as well as growing consciousness of the condition globally.
โข The inflammatory bowel disease treatment market demand is further increased by an aggregate of prominent businesses in the sector concentrating on R&D and probing contemporary probable contenders for curing IBD.
โข North America dominated the market with the largest share
โข APAC is expected to grow at the quickest rate during the forecast period.
๐๐๐๐ ๐๐จ๐ซ๐ ๐ ๐จ๐ซ ๐๐จ๐ฎ๐ซ ๐๐ฎ๐ฌ๐ข๐ง๐๐ฌ๐ฌ ๐๐ซ๐จ๐ฐ๐ญ๐ก ๐๐ข๐ซ๐๐๐ญ๐ฅ๐ฒ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐ซ๐: https://www.polarismarketresearch.com/buy/1555/2
๐๐ซ๐จ๐ฐ๐ญ๐ก ๐๐ซ๐ข๐ฏ๐๐ซ๐ฌ
โข Rising Prevalence of IBD: The global incidence of IBD is on the rise, contributing to increased demand for effective treatment options.
โข Advancements in Biotechnology and Pharmaceuticals: Innovations in drug development, including biologics and biosimilars, have significantly improved the efficacy of IBD treatments.
โข Increasing Awareness and Diagnosis: Improved diagnostic techniques and greater awareness among the public and healthcare providers have led to early detection and treatment of IBD.
โข Government and Private Sector Initiatives: Supportive policies, research funding, and collaborations between governments and private organizations are fueling market growth.
๐๐๐ ๐ข๐จ๐ง๐๐ฅ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ
โข North America (U.S., Canada)
โข Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
โข Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
โข Latin America (Brazil, Mexico, Argentina)
โข Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
๐๐๐๐๐ฌ๐ฌ ๐ญ๐ก๐ ๐๐ง๐ญ๐ข๐ซ๐ ๐๐จ๐ฆ๐ฉ๐ซ๐๐ก๐๐ง๐ฌ๐ข๐ฏ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐ซ๐: https://www.polarismarketresearch.com/industry-analysis/global-inflammatory-bowel-disease-ibd-market
๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ฅ ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค
๐๐ฒ ๐๐ข๐ฌ๐๐๐ฌ๐ ๐ข๐ง๐๐ข๐๐๐ญ๐ข๐จ๐ง
โข Crohn's Disease
โข Ulcerative Colitis
๐๐ฒ ๐๐ซ๐ฎ๐ ๐๐ฅ๐๐ฌ๐ฌ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ
โข Amino salicylates
โข Corticosteroids
โข TNF inhibitors
โข IL inhibitors
โข Anti-integrin
โข JAK inhibitors
โข Others
๐๐ฒ ๐๐จ๐ฎ๐ญ๐ ๐จ๐ ๐๐๐ฆ๐ข๐ง๐ข๐ฌ๐ญ๐ซ๐๐ญ๐ข๐จ๐ง
โข Oral
โข Injectable
๐๐ฒ ๐๐ข๐ฌ๐ญ๐ซ๐ข๐๐ฎ๐ญ๐ข๐จ๐ง ๐๐ก๐๐ง๐ง๐๐ฅ
โข Hospital Pharmacy
โข Retail Pharmacy
โข Online Pharmacy
๐๐ง๐๐ฅ๐๐ฆ๐ฆ๐๐ญ๐จ๐ซ๐ฒ ๐๐จ๐ฐ๐๐ฅ ๐๐ข๐ฌ๐๐๐ฌ๐ ๐๐ซ๐๐๐ญ๐ฆ๐๐ง๐ญ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ
โข In 2021, Crohn's disease dominated the IBD market. It is expected that the segment will remain dominant during the forecast period.
โข The injectable category dominated the market for the treatment of inflammatory bowel disease in 2021 with a revenue share. The segment's dominance is due to the great efficacy of injectable drugs.
โข The hospital pharmacy industry dominated the market for the treatment of inflammatory bowel disease in 2021, accounting for the largest revenue share. The sector is predicted to dominate the market during the forecasted period.
๐๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ ๐๐ข๐๐-๐ซ๐๐ง๐ ๐ข๐ง๐ ๐๐จ๐ฏ๐๐ซ๐๐ ๐ ๐จ๐ ๐๐๐'๐ฌ ๐๐๐๐ฅ๐ญ๐ก๐๐๐ซ๐ ๐๐๐ง๐๐ฌ๐๐๐ฉ๐:
๐๐๐ง๐ ๐๐ก๐๐ซ๐๐ฉ๐ฒ ๐๐๐ซ๐ค๐๐ญ: https://www.polarismarketresearch.com/industry-analysis/gene-therapy-market
๐๐๐ฅ๐ข๐ง๐ข๐๐๐ฅ ๐๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง๐ฌ ๐๐๐ซ๐ค๐๐ญ: https://www.polarismarketresearch.com/industry-analysis/eclinical-solutions-market
๐๐ข๐๐ซ๐จ๐ฌ๐๐จ๐ฉ๐ ๐๐๐ซ๐ค๐๐ญ: https://www.polarismarketresearch.com/industry-analysis/microscope-market
๐๐ฌ๐ญ๐จ๐ฆ๐ฒ/๐๐ญ๐จ๐ฆ๐ ๐๐๐ซ๐ ๐๐๐ซ๐ค๐๐ญ: https://www.polarismarketresearch.com/industry-analysis/ostomy-care-market
๐๐จ๐ง๐ญ๐๐๐ญ ๐๐ฌ:
Polaris Market Research
Phone: +1-929-297-9727
Email: sales@polarismarketresearch.com
๐๐๐จ๐ฎ๐ญ ๐๐ฌ:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Inflammatory Bowel Disease Treatment Market to Witness Substantial Growth USD 30.80 Billion, with a Dynamic 4.7% Growth Rate by 2030 here
News-ID: 3527523 • Views: โฆ
More Releases from Polaris Market Research & Consulting
Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of โฆ
Polaris Market Research has released new insights into the Granite market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors.
Market at a Glance
In 2024, the market was valued at USD 3.99 billion and is anticipated to grow to USD 6.63 Billion by 2034. Itโฆ
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 โฆ
Polaris Market Research announces the release of its latest study on the Molecular Diagnostics For Sexually Transmitted Diseases market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 3.82 billion in 2024 and is expected toโฆ
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expandin โฆ
Polaris Market Research announces the release of its latest study on the Higher Alpha Olefins market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 10.39 billion in 2024 and is expected to reach 20.01 billionโฆ
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2 โฆ
Polaris Market Research announces the release of its latest study on the Direct Oral Anticoagulants (DOACs) Device market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 31.67 billion in 2024 and is expected to reachโฆ
More Releases for IBD
Ace Therapeutics Unveils Imaging Services for Precise Characterization of IBD An โฆ
Ace Therapeutics launched its translational imaging services specifically designed to accurately characterize Inflammatory Bowel Disease (IBD) animal models.
New York, USA - May 28, 2025 - Ace Therapeutics, a leader in preclinical research solutions, launched its translational imaging solutions specifically designed to accurately characterize Inflammatory Bowel Disease (IBD) animal models. This breakthrough offering empowers researchers with high-resolution, quantitative data to enhance drug development and mechanistic studies.
Image: https://www.getnews.info/uploads/3c0755ac659fa5075e809ffd1b893496.jpg
Imaging techniques play a crucialโฆ
Inflammatory Bowel Disease (IBD) Market Size, Growth Insights, and Future Trends
Inflammatory Bowel Disease (IBD) continues to pose significant challenges for individuals and healthcare systems worldwide. With its increasing prevalence, the demand for effective treatments is driving market growth. The IBD treatment market is projected to grow from USD 19.91 billion in 2023 to USD 33.19 billion by 2032, reflecting a compound annual growth rate (CAGR) of 5.5% during the forecast period.
Download Statistical Data: https://www.towardshealthcare.com/download-statistics/5149
Key Market Highlights
โข Crohn's Disease Dominates: Crohn's diseaseโฆ
Canada Inflammatory Bowel Disease (IBD) Market Size & Growth Analysis Report, 20 โฆ
The Canada IBD market is estimated to grow significantly at a CAGR of around 5.2% during the forecast period. Rising prevalence and incidence of IBD across the country is the major driving factor for the market. Canada has among the highest reported prevalence and incidence rates of IBD across the globe. As per CCC, in 2018, nearly 270,000 Canadians were living with IBD, of which 135,000 individuals with Crohnโs disease,โฆ
Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031
Visiongain has published a new report on Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031: Forecasts by Drug Class (Biologics, Aminosalicylates, Corticosteroids, Antibiotics, Immunomodulators, Others), by Indication (Crohnโs Disease, Ulcerative Colitis), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) AND Regional and Leading National Market Analysis PLUS Analysis of Leading IBD Drug Companies AND COVID-19 Recovery Scenarios.
Global Inflammatory Bowel Disease (IBD) drugs market was valued at US$ US$xxโฆ
US Inflammatory Bowel Disease (IBD) Therapeutics Market Research and Forecast 20 โฆ
The US IBD therapeutics market is estimated to grow significantly at a CAGR of around 4.7% during the forecast period. The factors such as the significant prevalence of IBD such as Crohnโs disease and ulcerative colitis across the country contributing to the market growth. As per the Centers for Disease Control and Prevention (CDC), the prevalence of Crohnโs disease and ulcerative colitis in the US was 201 and 238 perโฆ
Global Inflammatory Bowel Disease (IBD) Therapeutics Market, Share, Trends & For โฆ
The global IBD therapeutics market is estimated to grow significantly at a CAGR of around 5.0% during the forecast period. The rise in the number of IBD such as Crohn's disease and ulcerative colitis is augmenting the growth of the global IBD therapeutics market. The increasing prevalence of IBD results in the need for research for the treatment of IBD and innovations in healthcare systems to manage this complex andโฆ
